Literature DB >> 1203541

Hypercoagulability and hypofibrinolysis in sickle-cell disease.

N E Stathakis, A G Papayannis, H Papayatos, P Scliros, C Gardikas.   

Abstract

Fifty-two patients with sickle-cell (SC) disease (48 with SC-beta-thalassaemia and 4 with homozygous SC-anaemia) were studied as regards blood coagulation and fibrinolysis. It was found that the thrombin and the reptilase times of the patients' plasma were significantly shorter than normal. The mean values of platelet count, fibrinogen level and factor VIII activity of patients with SC disease were higher than normal; however, in the group of patients transfused, with less than 50% haemoglobin S (HbS), the fibrinogen level and the factor VIII activity were significantly lower compared to the other patients. Antithrombin-III (At-III) activity was normal in all. The fibrinolytic activity was normal in patients with asymptomatic SC disease, but reduced in patients on painful crises. Plasminogen and fibrinogen/fibrin degradation product (FDP) levels were normal in all patients. Two patients on painful crises with complications had additional abnormal findings, namely prolonged prothrombin time, reduced At-III level and elevated FDP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1203541     DOI: 10.1007/bf01634001

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  17 in total

1.  A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma.

Authors:  R M HARDISTY; J C MACPHERSON
Journal:  Thromb Diath Haemorrh       Date:  1962-05-15

2.  Hematologic studies on patients with sickle cell anemia following multiple transfusions.

Authors:  C C DONEGAN; W A MACILWAINE; B S LEAVELL
Journal:  Am J Med       Date:  1954-07       Impact factor: 4.965

3.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

4.  Effect on blood coagulation of massive intravascular haemolysis.

Authors:  P M Mannucci; G F Lobina; L Caocci; N Dioguardi
Journal:  Blood       Date:  1969-02       Impact factor: 22.113

5.  Coagulation and fibrinolytic studies in paroxysmal nocturnal haemoglobinuria.

Authors:  C J Amris; N E Hansen
Journal:  Acta Med Scand       Date:  1968-12

6.  Assay of progressive antithrombin in plasma.

Authors:  U Abildgaard; K Gravem; H C Godal
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

7.  Fibrin degradation products in thrombo-embolic disease.

Authors:  D Sonnabend; D Cooper; P Fiddes; R Penny
Journal:  Pathology       Date:  1972-01       Impact factor: 5.306

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Fibrinolytic activity in the clinical crisis of sickle-cell anaemia.

Authors:  A Mahmood; D M Macintosh; A G Shaper
Journal:  Br Med J       Date:  1967-09-09

10.  Factor-8 (antihaemophilic factor) activity in sickle-cell anaemia.

Authors:  C F Abildgaard; J V Simone; I Schulman
Journal:  Br J Haematol       Date:  1967-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.